Skip to main content


Editorial | 21 February 2018
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen and Z. Katsarava

Consensus article | 16 January 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas and Paolo Martelletti

Research | 05 February 2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, Amelia Orejudos and Aubrey Manack Adams

Research | 01 February 2018
Poor medical care for people with migraine in Europe – evidence from the Eurolight study
Zaza Katsarava, Maka Mania, Christian Lampl, Johanna Herberhold and Timothy J. Steiner

Research | 24 May 2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades and Olivia Hogue

Research | 27 November 2018
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Paolo Martelletti, Todd J. Schwedt, Michel Lanteri-Minet, Rebeca Quintana, Veruska Carboni, Hans-Christoph Diener, Elena Ruiz de la Torre , Audrey Craven, Annette Vangaa Rasmussen, Simon Evans, Annik K. Laflamme, Rachel Fink, Donna Walsh, Paula Dumas & Pamela Vo

Consensus article | 08 October 2018
European Headache Federation guideline on idiopathic intracranial hypertension
Jan Hoffmann, Susan P Mollan, Koen Paemeleire, Christian Lampl, Rigmor H Jensen and Alexandra J Sinclair

Consensus article | 21 May 2019
Aids to management of headache disorders in primary care (2nd edition
T. J. Steiner, R. Jensen, Z. Katsarava, M. Linde, E. A. MacGregor, V. Osipova, K. Paemeleire, J. Olesen, M. Peters & P. Martelletti

Research article | 10 September 2018
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Pamela Vo, Juanzhi Fang, Aikaterini Bilitou, Annik K. Laflamme & Shaloo Gupta

Consensus article | 26 September 2018

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas, Fayyaz Ahmed, Patricia Pozo-Rosich & Paolo Martelletti

Source: Web of Science, data collected: July 2021

Important for Authors

  • If you are based in GermanyHungaryQatarSweden, you may publish your article open access with your fees covered by your institution. Check the list of eligible institutions that are included in the agreements.
  • If you are a corresponding author affiliated with the University of California (UC), you may be entitled to publish open access in our journals with funding support from the UC libraries.
  • Go through the Journal submission guidelines and learn about Fees and funding options 
  • Check if your institution has partnered with Springer Nature through the membership program 
  • Visit our OA funding and support service to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.

Academic education in headache

The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.

For more information:

MaSapienza Education in Headachester in Headache Medicine
Sapienza University 

University of CopenhagenMaster of Headache Disorders
University of Copenhagen

Editorial Office

Editor in Chief (Founding) 
Paolo Martelletti, MD, 
Department of Clinical and Molecular Medicine
Sapienza University of Rome 
Via di Grottarossa 1035 
I-00189 Rome, Italy 
Tel.: +39-06-33775111 
Fax: +39-06-33775110 

Aims and scope

The Journal of Headache and Pain is a peer-reviewed open access journal specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data. With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. Read more

Article collections

Click here to see the article collections and thematic series that the journal has published in recent years.

Q&A with Authors

Click here to see Q&As with the authors of the journal's most highly viewed articles!

Trending articles

Click here to view which articles were talked about the most in 2020!

Call for papers

European Headache Federation School of Advanced Studies

The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.

The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.

Editorial Board spotlight

New Content ItemDr. Bianca Raffaelli is a resident at the Department of Neurology of the Charité, Universitätsmedizin Berlin, Germany, and fellow of the Junior Clinician Scientist Program of the Berlin Institute of Health. Her research focuses on the influence of sex hormones on migraine.